KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY;충남대학교 산학협력단;한국화학연구원;THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY (IAC)
发明人:
KO, Young Kwan,고영관,KIM, Eun Ae,김은애,KOO, Dong Wan,구동완,KIM, Hwa-Jung,김화중,WHANG, Jake,황제익
申请号：
KRKR2018/003264
公开号：
WO2018/194274A1
申请日:
2018.03.21
申请国别(地区):
KR
年份:
2018
代理人:
摘要：
A pharmaceutical composition for treating nontuberculous mycobacteria infections is disclosed. The pharmaceutical composition provided in one aspect of the present invention exhibits an excellent antibacterial effect on nontuberculous mycobacteria and, particularly, has a very excellent antimicrobial effect during oral administration or parenteral administration (intraperitoneal injection), thereby being usable as an agent for treating nontuberculous mycobacteria infections.L'invention concerne une composition pharmaceutique permettant de traiter des infections à mycobactéries non tuberculeuses. La composition pharmaceutique selon un aspect de la présente invention présente un excellent effet antibactérien sur les mycobactéries non tuberculeuses et, en particulier, a un effet antimicrobien excellent lorsqu'elle est administrée par voie orale ou parentérale (injection intrapéritonéale), et est donc utilisable comme agent permettant de traiter des infections à mycobactéries non tuberculeuses.비결핵항산균 감염 질환 치료용 약학 조성물에 관한 것으로, 본 발명의 일 측면에서 제공되는 약학 조성물은 비결핵항산균에 우수한 항균효과를 나타내며, 특히 경구투여 또는 비경구투여 (복강 주입)에서 항균 효과가 매우 우수하여 비결핵항산균 감염 질환 치료제로 유용하게 사용될 수 있는 효과가 있다.
